Article Details
Retrieved on: 2019-04-27 23:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Galectin Therapeutics Inc (NASDAQ:GALT) institutional sentiment decreased to 1.06 in Q4 2018. Its down -0.23, from 1.29 in 2018Q3. The ratio has ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here